Ads
related to: flu vaccine
Search results
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 8 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 4 hours agoThese results, however, took a back seat to news of the partnership with Sanofi. Besides the rights to sell Novavax's existing COVID vaccine, Sanofi will...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 4 Kansas City· 15 hours ago...combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM adjuvantAnnounces addition of standalone influenza vaccine to Phase 3 COVID-19-Influenza...
Diet and metabolic health may influence flu vaccine effectiveness
MedicalNewsToday via AOL· 4 days agoA study conducted in obese mice found that dietary interventions resulting in weight loss led to...
Bird Flu: 100 Million Doses of Vaccine Could Be Shipped Within Months
Healthline· 3 days agoThe U.S. government has two candidate vaccine viruses for H5N1 bird flu that could be used to make...
Trials ongoing for three bird flu vaccines - BusinessWorld Online
BusinessWorld· 4 days agoTHE Department of Agriculture (DA) said on Monday that three Avian Influenza vaccines are currently...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 3 hours agoFurthermore, the company is preparing for the upcoming vaccination seasons by advancing its COVID-19 vaccine and initiating Phase 3 trials for its COVID-19-Influenza Combination (CIC) and standalone ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript May 8, 2024...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
NBC 17 Raleigh· 15 hours agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY). The ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 3 hours agoOn May 10, 2024, Novavax Inc (NVAX, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing. The company, a prominent player in the biotechnology ...